These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31033711)

  • 1. Brivaracetam for epilepsy.
    Hellerslia V; Asistido JM; Iyamu A
    JAAPA; 2019 May; 32(5):21-22. PubMed ID: 31033711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model.
    Sanon NT; Gagné J; Wolf DC; Aboulamer S; Bosoi CM; Simard A; Messiet E; Desgent S; Carmant L
    Epilepsy Behav; 2018 Feb; 79():117-125. PubMed ID: 29287214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of brivaracetam: a new drug to treat epilepsy.
    Milovanović JR; Janković SM; Pejčić A; Milosavljević M; Opančina V; Radonjić V; Protrka Z; Kostić M
    Expert Opin Pharmacother; 2017 Sep; 18(13):1381-1389. PubMed ID: 28737479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
    Strzelczyk A; Klein KM; Willems LM; Rosenow F; Bauer S
    Expert Rev Clin Pharmacol; 2016; 9(5):637-45. PubMed ID: 26891946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brivaracetam for the treatment of epilepsy.
    Klein P; Tyrlikova I; Brazdil M; Rektor I
    Expert Opin Pharmacother; 2016; 17(2):283-95. PubMed ID: 26760311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brivaracetam: An Adjunctive Treatment for Partial-Onset Seizures.
    Kappes JA; Hayes WJ; Strain JD; Farver DK
    J Clin Pharmacol; 2017 Jul; 57(7):811-817. PubMed ID: 28394442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brivaracetam: First Global Approval.
    Markham A
    Drugs; 2016 Mar; 76(4):517-22. PubMed ID: 26899665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with brivaracetam in children - The experience of a pediatric epilepsy center.
    Nissenkorn A; Tzadok M; Bar-Yosef O; Ben-Zeev B
    Epilepsy Behav; 2019 Dec; 101(Pt A):106541. PubMed ID: 31698260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brivaracetam for the treatment of epilepsy in adults.
    Mula M
    Expert Rev Neurother; 2014 Apr; 14(4):361-5. PubMed ID: 24625006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil.
    Wu PP; Cao BR; Tian FY; Gao ZB
    Neurosci Bull; 2024 May; 40(5):594-608. PubMed ID: 37897555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brivaracetam: new compound approved for the treatment of epilepsy.
    Zaccara G
    Drugs Today (Barc); 2016 Apr; 52(4):219-27. PubMed ID: 27252986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brivaracetam (Briviact) for epilepsy.
    Med Lett Drugs Ther; 2016 Jul; 58(1499):95-6. PubMed ID: 27403785
    [No Abstract]   [Full Text] [Related]  

  • 13. Human abuse potential of brivaracetam in healthy recreational central nervous system depressant users.
    Schoedel KA; Stockis A; Sellers EM
    Epilepsy Behav; 2018 Jan; 78():194-201. PubMed ID: 29153631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with brivaracetam in a series of 46 children.
    Visa-Reñé N; Raspall-Chaure M; Paredes-Carmona F; Coromina JS; Macaya-Ruiz A
    Epilepsy Behav; 2020 Jun; 107():107067. PubMed ID: 32302941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrapolation of a Brivaracetam Exposure-Response Model from Adults to Children with Focal Seizures.
    Schoemaker R; Wade JR; Stockis A
    Clin Pharmacokinet; 2018 Jul; 57(7):843-854. PubMed ID: 28884437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crossreactivity in antiepileptic drug monitoring: Reply to: Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy-a monocenter survey.
    Strasser B; Tomasits J
    Seizure; 2022 Jan; 94():115-116. PubMed ID: 34894439
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of brivaracetam on the anger levels of epilepsy patients. A prospective open-labelled controlled study.
    Toledo M; Abraira L; Mazuela G; Quintana M; Cazorla S; Santamarina E
    Seizure; 2019 Jul; 69():198-203. PubMed ID: 31079028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brivaracetam in adults with drug-resistant epilepsy and psychiatric comorbidities.
    Theochari E; Cock H; Lozsadi D; Galtrey C; Arevalo J; Mula M
    Epilepsy Behav; 2019 Jan; 90():129-131. PubMed ID: 30530134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study.
    Liguori C; Izzi F; Manfredi N; D'Elia A; Mari L; Mercuri NB; Fabio P
    Epilepsy Behav; 2018 Mar; 80():173-176. PubMed ID: 29414548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice.
    Villanueva V; López-González FJ; Mauri JA; Rodriguez-Uranga J; Olivé-Gadea M; Montoya J; Ruiz-Giménez J; Zurita J;
    Acta Neurol Scand; 2019 Apr; 139(4):360-368. PubMed ID: 30506559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.